Company news

Mesoblast Limited news in 2018

Mesoblast Limited's news releases, calls and decks from 2018, newest first.

View company

Response to ASX query

December 5, 2018

LVAD Results Webcast Presentation

November 12, 2018

LVAD Trial Results Provide Potential Regulatory Pathway

November 11, 2018

MSB Expands Partnership With JCR For Skin Disease

October 23, 2018

Completion of Tasly Transaction, and Appendix 3B

October 11, 2018

Day 180 Survival Outcomes In aGvHD Phase 3 Trial

September 20, 2018

Tasly Receives Approvals For Transaction With MSB

September 16, 2018

Mesoblast Reports on Annual and Fourth Quarter Results

August 29, 2018

Update on tasly transaction

August 28, 2018

MSB Enters Into Cardiovascular Alliance For China With Tasly

July 18, 2018

MSB Enters Into US$50M Financing With NovaQuest Capital

July 2, 2018

Key Day 100 Survival Results In P3 GvHD Trial

June 21, 2018

Partnership For Allogeneic Cell-based Cancer Immunotherapies

May 29, 2018

MSB Enters Into $75 Million Non-Dilutive Credit Facility

March 6, 2018

GVHD Day 28 Results Presentation

February 22, 2018

Primary Endpoint Successfully Achieved in MSB P3 GVHD Trial

February 21, 2018

Appendix 3B with prospectus

January 19, 2018

Decks in 2018